Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An extracellular vesicle delivery platform based on the PTTG1IP protein

Martin Perez C. et al, (2024), Extracellular Vesicle, 4, 100054 - 100054

Gene therapy for spinal muscular atrophy: timing is key.

Servais L., (2024), Lancet Reg Health Eur, 47

Spinal muscular atrophy in Brazil: from individual treatment to global management.

Servais L. and Moreno CAM., (2024), J Pediatr (Rio J)

Load More